These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29018805)

  • 1. Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.
    Watson GM; Lucas WAH; Gunzburg MJ; Wilce JA
    Front Mol Biosci; 2017; 4():64. PubMed ID: 29018805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
    Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
    J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
    Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
    BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain.
    Ambaye ND; Lim RC; Clayton DJ; Gunzburg MJ; Price JT; Pero SC; Krag DN; Wilce MC; Aguilar MI; Perlmutter P; Wilce JA
    Biopolymers; 2011; 96(2):181-8. PubMed ID: 20564009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.
    Ambaye ND; Pero SC; Gunzburg MJ; Yap M; Clayton DJ; Del Borgo MP; Perlmutter P; Aguilar MI; Shukla GS; Peletskaya E; Cookson MM; Krag DN; Wilce MC; Wilce JA
    J Mol Biol; 2011 Sep; 412(3):397-411. PubMed ID: 21802427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.
    Pero SC; Shukla GS; Cookson MM; Flemer S; Krag DN
    Br J Cancer; 2007 May; 96(10):1520-5. PubMed ID: 17426702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR analysis of G7-18NATE, a nonphosphorylated cyclic peptide inhibitor of the Grb7 adapter protein.
    Porter CJ; Wilce JA
    Biopolymers; 2007; 88(2):174-81. PubMed ID: 17206629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide.
    Yap MY; Wilce MC; Clayton DJ; Perlmutter P; Aguilar MI; Wilce JA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec; 66(Pt 12):1640-3. PubMed ID: 21139214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.
    Watson GM; Gunzburg MJ; Ambaye ND; Lucas WA; Traore DA; Kulkarni K; Cergol KM; Payne RJ; Panjikar S; Pero SC; Perlmutter P; Wilce MC; Wilce JA
    J Med Chem; 2015 Oct; 58(19):7707-18. PubMed ID: 26359549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
    Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
    J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.
    Gunzburg MJ; Kulkarni K; Watson GM; Ambaye ND; Del Borgo MP; Brandt R; Pero SC; Perlmutter P; Wilce MC; Wilce JA
    Sci Rep; 2016 Jun; 6():27060. PubMed ID: 27257138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the Bioactivity of Bicyclic Peptides Targeted to Grb7-SH2 by Restoring Cell Permeability.
    Sturre NP; Colson RN; Shah N; Watson GM; Yang X; Wilce MCJ; Price JT; Wilce JA
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
    Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
    Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
    J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.
    Ambaye ND; Gunzburg MJ; Traore DA; Del Borgo MP; Perlmutter P; Wilce MC; Wilce JA
    Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):182-6. PubMed ID: 24637751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one?
    Gunzburg MJ; Ambaye ND; Del Borgo MP; Perlmutter P; Wilce JA
    Biopolymers; 2013 Sep; 100(5):543-9. PubMed ID: 23505041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.
    Pias S; Peterson TA; Johnson DL; Lyons BA
    Crit Rev Immunol; 2010; 30(3):299-304. PubMed ID: 20370637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization.
    Luzy JP; Chen H; Gril B; Liu WQ; Vidal M; Perdereau D; Burnol AF; Garbay C
    J Biomol Screen; 2008 Feb; 13(2):112-9. PubMed ID: 18216394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.
    Ivancic M; Daly RJ; Lyons BA
    J Biomol NMR; 2003 Nov; 27(3):205-19. PubMed ID: 12975581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.